BACKGROUND: Understanding contributions of different brain pathologies to domain-specific cognitive trajectories in the oldest old is crucial to guide future intervention studies. METHODS: Two-hundred-twenty Oregon Alzheimer's Disease Center research participants who were cognitively intact at entry were followed on average for 7.3 years with annual neuropsychological testing until death (mean age, 93.7 y) and autopsy. Mixed effects models examined the relationship between trajectories in memory, verbal fluency, and mini-mental state examination (MMSE) and pathology (neurofibrillary tangles, neuritic plaques, gross infarcts, hippocampal sclerosis, Lewy bodies, APOE genotype, age at death, and years of education). The association between the MMSE trajectory and pathologic variables were examined using a Poisson model with MMSE errors as outcomes given the nonlinear distribution of MMSE scores. RESULTS: Memory trajectory was associated with the APOε4 allele (P=0.006). Verbal fluency trajectory was associated with gross infarcts (P=0.008). MMSE trajectory was associated with high Braak scores (P=0.03), gross infarcts (P<0.0001), hippocampal sclerosis (P=0.003), moderate neuritic plaques (P=0.04), and the APOε4 allele (P=0.02). CONCLUSIONS: The association between trajectory of decline in global cognitive scores and multiple brain pathologies highlights the importance of accounting for comorbid pathologies in therapeutic trials aimed at one specific pathology in the oldest old. Only the APOε4 allele showed an association with memory decline, despite accounting for Alzheimer's disease pathology, suggesting that APOE may be involved in mechanisms beyond amyloid metabolism in its role in memory. Further studies are needed to examine the role of APOE in brain aging.
BACKGROUND: Understanding contributions of different brain pathologies to domain-specific cognitive trajectories in the oldest old is crucial to guide future intervention studies. METHODS: Two-hundred-twenty Oregon Alzheimer's Disease Center research participants who were cognitively intact at entry were followed on average for 7.3 years with annual neuropsychological testing until death (mean age, 93.7 y) and autopsy. Mixed effects models examined the relationship between trajectories in memory, verbal fluency, and mini-mental state examination (MMSE) and pathology (neurofibrillary tangles, neuritic plaques, gross infarcts, hippocampal sclerosis, Lewy bodies, APOE genotype, age at death, and years of education). The association between the MMSE trajectory and pathologic variables were examined using a Poisson model with MMSE errors as outcomes given the nonlinear distribution of MMSE scores. RESULTS: Memory trajectory was associated with the APOε4 allele (P=0.006). Verbal fluency trajectory was associated with gross infarcts (P=0.008). MMSE trajectory was associated with high Braak scores (P=0.03), gross infarcts (P<0.0001), hippocampal sclerosis (P=0.003), moderate neuritic plaques (P=0.04), and the APOε4 allele (P=0.02). CONCLUSIONS: The association between trajectory of decline in global cognitive scores and multiple brain pathologies highlights the importance of accounting for comorbid pathologies in therapeutic trials aimed at one specific pathology in the oldest old. Only the APOε4 allele showed an association with memory decline, despite accounting for Alzheimer's disease pathology, suggesting that APOE may be involved in mechanisms beyond amyloid metabolism in its role in memory. Further studies are needed to examine the role of APOE in brain aging.
Authors: Lisa C Silbert; Hiroko H Dodge; Louie G Perkins; Lena Sherbakov; David Lahna; Deniz Erten-Lyons; Randall Woltjer; Lynne Shinto; Jeffrey A Kaye Journal: Neurology Date: 2012-07-25 Impact factor: 9.910
Authors: Peter T Nelson; John Q Trojanowski; Erin L Abner; Omar M Al-Janabi; Gregory A Jicha; Frederick A Schmitt; Charles D Smith; David W Fardo; Wang-Xia Wang; Richard J Kryscio; Janna H Neltner; Walter A Kukull; Matthew D Cykowski; Linda J Van Eldik; Eseosa T Ighodaro Journal: J Neuropathol Exp Neurol Date: 2016-05-21 Impact factor: 3.685
Authors: J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark Journal: Neurology Date: 1989-09 Impact factor: 9.910
Authors: Lei Yu; Patricia Boyle; Julie A Schneider; Eisuke Segawa; Robert S Wilson; Sue Leurgans; David A Bennett Journal: Psychol Aging Date: 2013-05-06
Authors: Alexandra M Wennberg; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Mary M Machulda; Leonard Petrucelli; Michelle M Mielke; Clifford R Jack; David S Knopman; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Keith A Josephs Journal: Neurobiol Aging Date: 2019-01-21 Impact factor: 4.673
Authors: Yichen Jia; Chung-Chou H Chang; Tiffany F Hughes; Erin Jacobsen; Shu Wang; Sarah B Berman; M Ilyas Kamboh; Mary Ganguli Journal: Alzheimer Dis Assoc Disord Date: 2020 Oct-Dec Impact factor: 2.357
Authors: Sarah L Booth; M Kyla Shea; Kathryn Barger; Sue E Leurgans; Bryan D James; Thomas M Holland; Puja Agarwal; Xueyan Fu; Jifan Wang; Gregory Matuszek; Julie A Schneider Journal: Alzheimers Dement (N Y) Date: 2022-04-20
Authors: James C McGann; Michael A Spinner; Saurabh K Garg; Karin A Mullendorff; Randall L Woltjer; Gail Mandel Journal: J Neurosci Date: 2021-07-01 Impact factor: 6.167